Stenting May Improve Transplant Renal Artery Stenosis Outcomes
Angioplasty plus stenting is associated with less residual stenosis and a lower restenosis rate compared with angioplasty alone.
Angioplasty plus stenting is associated with less residual stenosis and a lower restenosis rate compared with angioplasty alone.
Both approaches are associated with similar outcomes in patients with renal artery stenosis and CKD or hypertension.
Easing stenosis in transplanted renal arteries improves kidney function.
Revascularization of renal artery stenosis in patients with atherosclerotic renovascular disease has no effect on renal perfusion.
Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in patients treated with renal artery stenting, according to results from the HERCULES trial.
CHICAGO—Drug-eluting stents (DES) may achieve better outcomes than bare metal stents in the treatment of renal artery stenosis (RAS), according to researchers.
Revascularization offers little or no “worthwhile clinical benefit” over medical treatment for patients with renal artery stenosis, regardless of the extent of their renal disease, researchers concluded.
An interventional cardiologist and two nephrologists debate the issue at a major medical conference.
Renal frame count can indicate likelihood of successful outcomes in patients with renal hypertension